Every facility manager who lived through 2020 learned the same lesson: a great product you cannot get is worth nothing. That lesson is built into how Covexall is manufactured and delivered, and it is a core part of why institutions can standardize on it.
Capacity with headroom
Per the Covexall white paper, manufacturing runs through partner facilities both in the United States and abroad, with production capacity documented at over 200,000 gallons per day, per shift — and additional facilities planned to double that figure. For buyers, the number matters less than what it means: surge demand from a single health system, district, or agency does not move the needle on availability.
Packaging for every point of use
- Personal: one-ounce airless pumps and four-ounce squeeze bottles
- Facility: gallons and automatic dispenser bladders for wall units
- Bulk: five-gallon pails and totes from 25 up to 250 gallons
One formulation across every format means a facility can run pocket bottles, wall dispensers, and refill programs without managing multiple products or data sheets.
Delivered by a supplier that ships for a living
Covexall moves through ASP's own distribution: nationwide fulfillment across all fifty states, freight coordination for pallet and tote volumes, and the compliant documentation government receiving requires. Product, packaging, capacity, and logistics under one roof — which is precisely the promise an in-house brand is supposed to keep.
Covexall is a topical hand sanitizer for external use only. Performance figures referenced in this article are drawn from the 2022 Covexall white paper and the independent laboratory studies cited in it, including testing conducted at Arizona State University's Biodesign Institute. Continued antimicrobial activity lasts up to four hours after application.
